-
Product Insights
NewPancreatic Diseases – Drugs In Development, 2024
Empower your strategies with our Pancreatic Diseases – Drugs In Development, 2024 report and make more profitable business decisions. Pancreatic diseases encompass a range of conditions that affect the pancreas, a vital organ located behind the stomach. The pancreas plays a crucial role in digestion and hormone regulation by producing enzymes for digestion and hormones like insulin and glucagon that regulate blood sugar levels. The Pancreatic Diseases drugs in development market research report provide comprehensive information on the therapeutics under development...
-
Sector Analysis
United States (US) Power Market Trends and Analysis by Capacity, Generation, Transmission, Distribution, Regulations, Key Players and Forecast to 2035
United States (US) Power Market Report Overview The cumulative installed capacity in the United States (US) power market was 1310.5 GW in 2022. In 2022, thermal power dominated the capacity segment, followed by renewable and nuclear power. The installed capacity in the US power market is expected to grow at a CAGR of more than 3% during 2022-2035, owing to the rapid growth in the country’s renewable power. US Power Market Outlook, 2022-2035 (GW) Buy the Full Report for More...
-
Product Insights
NewRecurrent Glioblastoma Multiforme (GBM) – Drugs In Development, 2024
Empower your strategies with our Recurrent Glioblastoma Multiforme (GBM) – Drugs In Development, 2024 report and make more profitable business decisions. Recurrent glioblastoma multiforme (GBM) refers to the return of aggressive brain tumors known as glioblastomas after initial treatment. GBM is the most malignant type of glioma, characterized by rapid growth and infiltrative behavior. Despite aggressive therapies like surgery, radiation, and chemotherapy, GBM often recurs due to its invasive nature and resistance to treatment. Management of recurrent GBM poses significant challenges....
-
Thematic Analysis
Hydrogen in Power – Thematic Intelligence
Hydrogen in Power Thematic Report Overview Green hydrogen via electrolysis is one of the most promising and sustainable technologies within the power sector. Industries, where greenhouse gas emissions are harder to suppress, are investing heavily in it owing to its versatility. In addition, the production of Hydrogen from renewable electricity will play a vital role in the realization of long-term decarbonization goals and improvement in energy security. Greater demand for renewable hydrogen will determine the pace of dedicated renewable capacity...
-
Thematic Analysis
Power Predictions in 2024 – Thematic Intelligence
Exploring the trends and insights from the ‘Power Predictions’ thematic intelligence report will help you: Understand the top 20 themes, namely AI, big data, blockchain, cloud, cybersecurity, digitalization, IoT, the metaverse, robotics, electric vehicles, energy storage, energy transition, hydrogen, nuclear, renewable energy, smart grid, carbon emissions, distributed generation, geopolitics, and ESG-environmental, that will impact the power industry in 2024. Analyze the predictions concerning technology theme, macroeconomic theme, industry theme, and ESG theme in the power sector. Get an overview of deal...
-
Product Insights
NewBatten Disease – Drugs In Development, 2024
Empower your strategies with our Batten Disease – Drugs In Development, 2024 report and make more profitable business decisions. Batten disease, a rare genetic disorder, belongs to a group of progressive degenerative neurometabolic disorders known as the neuronal ceroid lipofuscinoses. Symptoms of Batten disease usually become apparent between five and 15 years of age. Symptoms include vision loss, lack of muscle coordination, mental retardation or decreasing mental function, emotional disturbances, seizures, muscle spasms, deterioration of muscle tone, and movement problems. The...
-
Product Insights
NewLeukodystrophies – Drugs In Development, 2024
Empower your strategies with our Leukodystrophies – Drugs In Development, 2024 report and make more profitable business decisions. Leukodystrophies, a collection of rare genetic disorders impacting the central nervous system (CNS), specifically the brain and spinal cord, cause damage to the CNS's white matter. This damage hampers or obstructs signals between nerve cells, resulting in varied symptoms such as movement difficulties, vision and hearing impairment, and cognitive challenges. Due to the multitude of leukodystrophy types with differing symptoms, diagnosis poses a...
-
Product Insights
NewTay-Sachs Disease – Drugs In Development, 2024
Empower your strategies with our Tay-Sachs Disease – Drugs In Development, 2024 report and make more profitable business decisions. Tay-Sachs disease is a rare, inherited metabolic disease that mostly affects young children and involves progressive damage to and death of cells, particularly in the brain. It is caused by a mutation in the enzyme hexosaminidase A, which allows the harmful buildup of lipids (fatty materials such as oils and acids) in cells. Both parents must carry the mutated gene in order...